ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma.
ViaLase has raised $40.0M in total funding. The most recent round was Series C. The last funding was announced in April 2024.
ViaLase's investors include Arboretum Ventures, Versant Ventures, Venture Investors, Falcon Vision.
ViaLase is headquartered in Corona Del Mar, United States.
ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma.
ViaLase is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ViaLase — Funding & Investors." VCBacked, April 1, 2024, https://www.vcbacked.co/company/vialase. Accessed September 15, 2026.
VCBacked. (2024). ViaLase — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/vialase
{{cite web |title=ViaLase — Funding & Investors |url=https://www.vcbacked.co/company/vialase |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated